发明名称 S1P receptors modulators
摘要 The invention relates to novel compounds that have S1P receptor modulating activity and, preferably, apoptotic activity and/or anti proliferative activity against cancer cells and other cell types. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, cancer. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as cancer.
申请公布号 US9181182(B2) 申请公布日期 2015.11.10
申请号 US200913124543 申请日期 2009.10.16
申请人 Akaal Pharma PTY LTD 发明人 Grobelny Damian W.;Gill Gurmit S.
分类号 A61K31/136;C07D209/44;C07D215/06;C07D209/08;C07C215/18;C07C217/72;C07C225/16;C07C311/16;C07D209/12;C07D209/38;C07D215/20;C07D217/04;C07D223/16;C07D405/12;C07D413/10;C07D413/14 主分类号 A61K31/136
代理机构 Cooley LLP 代理人 Cooley LLP ;Erlacher Heidi A.;Ouyang Lian
主权项 1. A compound having the structure of any one of formulae (8) to (13), or a stereoisomer, isotopic form, or pharmaceutically acceptable salt thereof:wherein X is N; X1 is O or S; R3 is hydrogen, deuterium, alkoxy, cyano, amino, hydroxyl, halogen, nitro, carbonyl, carboxy, amido, trifluoromethyl, trihaloalkyl, trifluoroalkoxy or a C1-8 substituted or unsubstituted alkyl, alkenyl or alkynyl; R4 is hydrogen, alkoxy, cyano, amino, hydroxyl, halogen, nitro, carbonyl, carboxy, amido, trifluoromethyl, trihaloalkyl, trifluoroalkoxy or a C1-8 substituted or unsubstituted alkyl, alkenyl or alkynyl, R5 is hydrogen or —P(O)(ORx)(ORy) wherein each of Rx and Ry independently is hydrogen, alkoxy, cyano, amino, hydroxyl, halogen, nitro, carbonyl, carboxy, amido, trifluoromethyl, trihaloalkyl, trifluoroalkoxy or a C1-8 substituted or unsubstituted alkyl, alkenyl or alkynyl; or R4 and R5 together form —O—(P—)(O)(OR7) wherein R7 is selected from the group consisting of hydrogen, trifluoromethyl, trihaloalkyl or a C1-8 substituted or unsubstituted alkyl, alkenyl or alkynyl and salts; A is hydrogen, deuterium or optionally substituted (C1-C20)alkyl, (C3-C20)cycloalkyl, (C3-C18)cycloalkyl(C1-C18)alkyl, (C6-C24)aryl, (C7-C25)aralkyl, (C2-C18)alkenyl, (C8-C26)aralkenyl, (C2-C18)alkynyl, (C8-C26)aralkynyl, heterocyclic or optionally substituted sulfonamide; R1 is hydrogen, deuterium or optionally substituted (C1-C18)alkyl, (C3-C18)cycloalkyl, (C3-C18)cycloalkyl(C1-C18)alkyl, (C6-C24)aryl, (C7-C25)aralkyl, (C2-C18)alkenyl, (C8-C26)aralkenyl, (C2-C18)alkynyl, (C8-C26)aralkynyl, (C8-C26)polycycloalkyl, substituted or unsubstituted heterocyclic, substituted or unsubstituted heteroaryl, substituted C1-20alkyl, C3-20 cycloalkyl substituted aryl, C3-20 cycloalkyl substituted heteroaryl, heteroaryl substituted C2-20 alkenyl, heteroaryl substituted C2-20 alkynyl, aryl substituted alkoxyl, C3-20 cycloalkyl substituted aryl alkoxyl, alkylaryl substituted alkoxyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroaryloxy, fused 4-5, 4-6, 5-5, 5-6 or 6-6 heterobicylic ring system, or a group (a-d), wherein Ar is an optionally substituted 5-12 atom aromatic or heteroaromatic ring system; B, C, D, E and F are independently selected from C(R)n, O, S(O)n, and N(R)n; G and H are independently hydrogen, deuterium or optionally substituted (C1-C20)alkyl, (C3-C20)cycloalkyl, (C3-C18)cycloalkyl(C1-C18)alkyl, (C6-C24)aryl, (C7-C25)aralkyl, (C7-C18)alkenyl, (C8-C26)aralkenyl, (C2-C18)alkynyl, (C826)aralkynyl, optionally substituted sulfonamide, (C8-C26)polycycloalkyl, substituted or unsubstituted heterocyclic, substituted or unsubstituted heteroaryl, C3-20 cycloalkyl substituted aryl, C3-20 cycloalkyl substituted heteroaryl, heteroaryl substituted C2-20 alkenyl, heteroaryl substituted C2-20 alkenyl, aryl substituted alkoxyl, C3-20 cycloalkyl substituted aryl alkoxyl, alkylaryl substituted alkoxyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heteroaryloxy, or fused 4-5, 4-6, 5-5, 5-6 or 6-6 heterobicylic ring system; Q and Q1 are independently represented by —{C(R)2}m—X′—*, the asterisk indicating the bond that is linked to the phenyl ring of any one of formulae (8) to (13), m is 0-5; X′ is C(R)n, N(R)n, O, S(O)n or C(O) in groups (b) and (c); X′, Y and Z are independently C(R)n″, or N in group (d); R is hydrogen, deuterium, alkoxy, cyano, amino, hydroxyl, halogen, nitro, carbonyl, carboxy, amido, trifluoromethyl, trihaloalkyl, trifluoroalkoxy or a C1-8 substituted or unsubstituted alkyl, alkenyl or alkenyl; R′ and R′1 are independently hydrogen, deuterium, alkoxy, cyano, amino, hydroxyl, halogen, nitro, carbonyl, carboxy, amido, trifluoromethyl, trihaloalkyl, trifluoroalkoxy or a C1-8 substituted or unsubstituted alkyl, alkenyl or alkynyl; n is 0-2; and n″ is 0-1.
地址 Bundoora AU